As we head into the winter months, protecting older adults from preventable respiratory illness is more important than ever. CESPHN is encouraging eligible community members to access the new free Respiratory Syncytial Virus (RSV) vaccine, funded by the Australian Government under the National Immunisation Program from 15 May 2026.
Why vaccinate older Australians for RSV?
RSV is common – and can be severe in older people. RSV is a highly infectious respiratory virus that usually causes mild, cold‑like symptoms, but in older adults it can lead to severe disease. RSV can cause pneumonia and bronchitis and, in some cases, result in hospitalisation, intensive care admission or death. Older people, particularly those living in aged care or with chronic health conditions, are at higher risk due to reduced immunity and close living environments.
Why this matters for our community
This new RSV vaccination program reduces preexisting financial barriers to health care and complements existing free flu and COVID‑19 vaccines, strengthening protection for those most at risk of severe respiratory illness.
Vaccination not only protects individuals but helps reduce the spread of illness across the community—supporting healthier families, carers and aged care residences.
How do older Australians access the RSV vaccine?
From May 15, 2026, a free RSV vaccine is available for:
People aged 75 years and over
Aboriginal and Torres Strait Islander people aged 60 years and over
Eligible people can receive the vaccine through their GP, local immunisation clinic, community or Aboriginal health service, or participating pharmacy.
Community members are encouraged to speak with their healthcare provider about RSV vaccination and staying up to date with all recommended immunisations this winter.
See Department of Health, Disability and Aging media release here.
See National Immunisation Program RSV consumer fact sheet here.
New universal antenatal syphilis screen introduced at 36 weeks gestation NSW Health has updated the Policy Directive Syphilis in Pregnancy and Newborns (PD2026_044) to strengthen the prevention of congenital syphilis and align with the updated Australian Pregnancy Care Guidelines. Under the revised Policy Directive, syphilis screening should be offered to…
SESLHD State-Wide Referral Criteria (SRC) SESLHD is preparing to implement the next phase of the NSW Statewide Referral Criteria (SRC) for referrals to public hospital outpatient services. The SRC establishes consistent clinical referral requirements across NSW, helping general practitioners and other referrers to: Determine when referral to a public outpatient…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: COVID-19 vaccination in 2026: preparing for the transition to the National Immunisation Program (NIP) Webinar COVID-19 vaccine stock RSV now Australia’s most notified respiratory virus: a timely reminder to check vaccine status Education COVID-19 vaccination…
New NSW medicines and poisons legislation commences 5 November 2026 New NSW medicines and poisons legislation will commence on 5 November 2026, replacing the current regulatory framework with the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026. The changes introduce new requirements…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update, read about: Transition of COVID-19 vaccines to the NIP Hep B vaccine eligibility No link between vaccines and autism Expansion of the NIP Vaccinations in Pharmacy Program to include children under 5 years National Vaccination Insights project…
HealthPathways is getting a refreshed look From 17 September 2026, HealthPathways Sydney and South Eastern Sydney sites will launch a refreshed layout designed to provide a clearer and more user-friendly experience. New features: Simplified homepage More prominent search bar Improved toolbar for common actions – including CPD notes and expand/collapse…